Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Dr. Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Doctor at Medical University, Varna, Bulgaria

Dr. Yoana Dyankova Dyankova is a dedicated pediatrician and clinical researcher specializing in pediatric gastroenterology, hepatology, and nutrition. She holds a PhD in Pediatrics from the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, where she also serves in the Pediatric Intensive Care Unit at St. Marina University Hospital. Her research focuses primarily on celiac disease in children, particularly its impact on bone health, as demonstrated in her dissertation and multiple peer-reviewed publications, including a recent article in Nutrients (2025). Dr. Dyankova is an active member of national pediatric and gastroenterology associations and contributes to both clinical care and academic development. Fluent in English and German, she engages with the international scientific community and remains committed to translating research into improved patient outcomes. With her growing publication record, clinical integration, and academic rigor, she stands out as a promising young researcher in the field of pediatric medicine.

Professional Profile 

Google Scholar
ORCID Profile 

Education

Dr. Yoana Dyankova Dyankova began her academic journey at the Vasil Drumev High School of Natural Sciences and Mathematics in Veliko Tarnovo, graduating in 2010. She pursued her medical degree at the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, completing it in 2016. From 2017 to 2022, she specialized in pediatrics, gaining comprehensive clinical training and board certification in the field. In 2018, she enrolled in a PhD program in Pediatrics at the same university, where she focused her research on celiac disease and its effects on pediatric bone health. She successfully defended her dissertation in 2023. Dr. Dyankova has since continued to develop professionally by pursuing further specialization in pediatric gastroenterology starting in July 2025. Her academic path demonstrates strong commitment, discipline, and a focused interest in improving pediatric healthcare through both clinical practice and rigorous scientific research.

Professional Experience

Dr. Dyankova has cultivated a balanced career combining clinical excellence and academic growth. Since January 2022, she has served as a pediatrician at the Pediatric Intensive Care Unit (PICU) of the First Children’s Clinic, St. Marina University Hospital in Varna. Her role in the PICU places her at the frontline of managing critically ill children, often requiring advanced decision-making and teamwork in high-pressure situations. Prior to this, she completed a five-year pediatric residency, gaining hands-on experience in general pediatrics. Her transition into the subspecialty of pediatric gastroenterology as of July 2025 marks a strategic shift aligned with her research interests. Parallel to her clinical duties, Dr. Dyankova was engaged in doctoral studies for five years, conducting original research and contributing to academic publications. Her dual role as both a clinician and researcher enhances her ability to apply scientific findings directly to patient care, making her a valuable asset in modern pediatric medicine.

Research Interest

Dr. Dyankova’s primary research interests lie at the intersection of pediatric gastroenterology, hepatology, and nutrition, with a concentrated focus on celiac disease (CD). Her doctoral thesis explored bone health in children with CD, addressing the metabolic and developmental complications arising from malabsorption and chronic inflammation. Beyond celiac disease, she has expressed research interest in related gastrointestinal disorders such as inflammatory bowel disease (IBD), as well as broader issues within pediatric intensive care. Her work is characterized by clinical relevance and translational value, aiming to bridge the gap between scientific research and bedside care. Publications in both national and international journals reflect her dedication to improving diagnostic and treatment protocols in children with chronic gastrointestinal conditions. Dr. Dyankova continues to build her research portfolio by participating in collaborative studies, focusing on early diagnosis, nutritional interventions, and long-term management outcomes in affected pediatric populations, ensuring a direct impact on clinical practice.

Award and Honor

While specific named awards are not listed in the biography, Dr. Yoana Dyankova Dyankova has received notable academic and professional recognition through her successful completion of a PhD and multiple scientific publications. Her research has been published in reputable journals such as Nutrients, indicating peer validation and relevance of her work. She is an active member of the National Pediatric Association and the community of Pediatric Gastroenterologists in Bulgaria, reflecting her standing in the professional community. These memberships signify not only recognition by peers but also her continued contribution to scientific discussions and advancements in pediatric healthcare. Her role in high-stakes clinical environments like the Pediatric Intensive Care Unit further demonstrates trust in her medical competence and decision-making. With growing academic output and clear specialization in a crucial field, Dr. Dyankova is well-positioned to earn future distinctions and leadership roles in pediatric research and clinical practice at both national and international levels.

Conclusion

Dr. Yoana Dyankova Dyankova exemplifies the qualities of a dedicated clinician-scientist, balancing hands-on pediatric care with high-impact academic research. With a solid foundation in pediatrics and a focused interest in gastroenterology and nutrition, she has steadily advanced her career through both clinical excellence and scholarly contribution. Her doctoral work on bone health in children with celiac disease highlights her ability to address complex, real-world health challenges through evidence-based research. Now working in a pediatric intensive care setting and continuing her subspecialty training, Dr. Dyankova is expanding her expertise and influence in critical areas of child health. Her publications, professional affiliations, and academic achievements underscore a deep commitment to the advancement of pediatric medicine. While still early in her career, her trajectory suggests strong potential for leadership in research and healthcare. She is a promising candidate for recognition such as the Best Researcher Award and is well-poised for continued professional impact.

Publications Top Notes

  1. Title: Presentation of Childhood Newly-Diagnosed Diabetes During the COVID-19 Pandemic – Is There a Change?

    • Authors: Y. Bazdarska, V. Iotova, T. Karamfilova, Y. Dyankova, T. Stefanova, …

    • Journal: Diabetes Technology & Therapeutics, Vol. 23, A202

    • Year: 2021

  1. Title: Delayed Bone Age and Osteoprotegerin Levels in Pediatric Celiac Disease: A Three-Year Case–Control Study

    • Authors: R. Pancheva, Y. Dyankova, N. Rasheva, K. Koleva, V. Iotova, M. Dzhogova, M. Fiore, M. Georgieva

    • Journal: Nutrients, Vol. 17 (14), Article 2295

    • Year: 2025

  1. Title: Macrophage Activation Syndrome After COVID-19 Infection in a Patient with Systemic Juvenile Idiopathic Arthritis

    • Authors: M. Boyadzhiev, B. Varbanova, M. Belcheva, P. Shivachev, D. Krumova, Y. Dyankova, …

    • Journal: Scripta Scientifica Medica, Vol. 55(1), pp. 27–31

    • Year: 2023

  1. Title: Bone Health in Children with Celiac Disease (PhD Dissertation)

    • Author: Y. Dyankova

    • Database: PQDT-Global (ProQuest Dissertations)

    • Year: 2022

  1. Title: New Developments in the Diagnostics of Celiac Disease in Children

    • Authors: Y. Dyankova, M. Georgieva, N. Rasheva, K. Koleva

    • Journal: Journal of the Union of Scientists-Varna. Medicine and Ecology Series, Vol. 24(1)

    • Year: 2019

  1. Title: Bacterial Pulmonary Colonization with Pseudomonas aeruginosa in Cystic Fibrosis Patients

    • Authors: M. Nikolova, Y. Dyankova, I. Hristov, M. Georgieva

    • Journal: Izvestia Journal of the Union of Scientists-Varna. Medicine and Ecology Series

    • Year: 2019

Dr. Javier Crespo | Medicine and Dentistry | Best Researcher Award

Dr. Javier Crespo | Medicine and Dentistry | Best Researcher Award

Professor at IDIVAL, Spain

Professor Javier Crespo is a distinguished physician-scientist and academic leader in the field of digestive and liver diseases. Currently a Professor of Medicine at the University of Cantabria and Director of the Translational Research in Digestive Pathology group at IDIVAL, he has made significant contributions through over 400 original publications, more than 120 clinical trials, and leadership in numerous national and international research projects. With an H-index of 70 and over 30,000 citations, his work has had a profound global impact. He has played a pivotal role in national health strategies, including Spain’s Hepatitis C elimination plan, and served as President of major professional societies such as SEPD. A mentor to numerous doctoral and master’s students, he has also received multiple prestigious awards for his contributions to medicine and research. His leadership at Marqués de Valdecilla University Hospital earned repeated national recognition for excellence in digestive and hepatitis care.

Professional Profile 

Google Scholar
Scopus Profile
ORCID Profile 

Education

Professor Javier Crespo earned his Degree in Medicine and General Surgery from the University of Cantabria with an Outstanding qualification. He later obtained his Doctorate in Medicine in 1993, receiving the Extraordinary Doctorate Award for academic excellence. His formal education laid a strong foundation for a career marked by clinical rigor and academic depth. In addition to his medical qualifications, he has been accredited as a Professor by ANECA (the Spanish National Agency for Quality Assessment and Accreditation). His academic journey reflects not only excellence in performance but also an enduring commitment to scientific learning and advancement. His scholarly trajectory is rooted in a lifelong dedication to the field of hepatology and digestive pathology, with an early focus on merging basic medical science with clinical research. These formative years have played a crucial role in shaping his influential career in medicine, teaching, and research.

Professional Experience

Professor Crespo has held several prestigious positions throughout his career. He is a Professor of Medicine at the University of Cantabria and Director of the Translational Research in Digestive Pathology group at IDIVAL. He served as Head of the Digestive Service at Marqués de Valdecilla University Hospital from 2010 to 2024. Additionally, he has played strategic roles in healthcare governance, including being a member of Spain’s National Strategic Plan against Hepatitis C since 2015 and coordinator of the AEEH National Liver Health Plan Challenge 2032. His leadership extends to professional societies—he served as President of the Spanish Society of Digestive Pathology (SEPD), President of the National Digestive Commission, and Secretary of the Spanish Association for the Study of the Liver. His professional career reflects a unique blend of clinical excellence, policy leadership, academic mentoring, and research management, making him one of the most respected figures in his specialty.

Research Interest

Professor Crespo’s primary research interests center around digestive and liver diseases, with a particular focus on hepatitis C, liver cirrhosis, and inflammatory bowel diseases. He has led more than 120 clinical trials across Phases I–III and participated in 15 national and 8 international competitive research projects. His translational approach bridges laboratory findings with clinical application, especially in hepatology. Under his leadership, the IDIVAL research group has produced high-impact findings in digestive pathology and liver disease progression. He has authored over 400 original scientific articles, with a strong presence in high-impact journals. His work is cited more than 30,000 times, and he holds an H-index of 70, underscoring his global influence. He is also actively involved in supervising doctoral and postgraduate theses, reflecting his dedication to advancing the next generation of researchers in gastroenterology. His research has contributed significantly to public health, particularly in the management and elimination of hepatitis C.

Award and Honor

Professor Javier Crespo has received numerous national and international awards that recognize both his scientific excellence and public health impact. Among his most prestigious accolades are the Elimination Champions 2023 International Award, granted by the Coalition for Global Hepatitis Elimination, and the International Award at the VI LIFE Forum for HCV Elimination in Lima (2024). Nationally, he has been honored with the Commendation of the Civil Order of Health, the SEPD Gold Medal, and the ACAD Gold Medal. He was also named an Illustrious Torrelaveguense in 2024. Under his leadership, the Digestive Service at Marqués de Valdecilla University Hospital received the Best in Class Award for several consecutive years for excellence in digestive and hepatitis care. His honors reflect not only scientific merit but also his dedication to clinical service and public health leadership, making him one of the most decorated professionals in his field.

Conclusion

In conclusion, Professor Javier Crespo is a highly accomplished and impactful leader in the fields of gastroenterology and hepatology. His career combines outstanding academic achievement, clinical leadership, and translational research excellence. With more than 30,000 citations and an H-index of 70, his scientific contributions have shaped current practices in liver disease treatment and public health strategies. He has held top-level positions in hospitals, universities, research institutes, and national health commissions, evidencing his multifaceted influence. Through his mentorship, he has cultivated a generation of researchers and clinicians, further extending his legacy. His work has not only garnered national and international recognition through prestigious awards but has also led to meaningful improvements in patient care, especially in hepatitis C management. Professor Crespo exemplifies the qualities of a visionary researcher, a compassionate physician, and a dedicated educator—making him exceptionally worthy of recognition such as the Best Researcher Award.

Publications Top Notes

  • Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis

    • Authors: Not listed

    • Year: 2025

    • Citations: 3

  • Letter to the Editor: Optimizing MASLD treatment—A “lead-in phase” before resmetirom

    • Authors: Not listed

    • Year: Not listed

    • Citations: 1

  • Comprehensive Diagnosis of Viral Hepatitis in Spain: Bases for Implementation

    • Authors: Not listed

    • Year: 2025

  • Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions

    • Authors: Not listed

    • Year: Not listed

    • Citations: 1

  • A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    • Authors: ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, …

    • Year: 2023

    • Citations: 4,096

  • Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn’s disease

    • Authors: N Inohara, Y Ogura, A Fontalba, O Gutierrez, F Pons, J Crespo, K Fukase, …

    • Year: 2003

    • Citations: 2,245

  • Modeling NAFLD disease burden in 8 countries (2016–2030)

    • Authors: C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, …

    • Year: 2018

    • Citations: 2,027

  • A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

    • Authors: HSA Newsome, PN Buchholtz, K Cusi, M Linder, T Okanoue, V Ratziu, S Sanyal, …

    • Year: 2021

    • Citations: 1,673

  • Obeticholic acid for the treatment of NASH: Phase 3 trial analysis

    • Authors: ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, …

    • Year: 2019

    • Citations: 1,286

  • Elafibranor resolves NASH without fibrosis worsening

    • Authors: SA Ratziu, V Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, …

    • Year: 2016

    • Citations: 1,217

  • Sofosbuvir and ribavirin in HCV genotypes 2 and 3

    • Authors: ER Zeuzem, S Dusheiko, GM Salupere, R Mangia, A Flisiak, RH Hyland, …

    • Year: 2014

    • Citations: 1,048

  • A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis

    • Authors: Not listed

    • Year: 2024

    • Citations: 983

  • Gene expression of TNF-α and TNF receptors in NASH patients

    • Authors: J Crespo, A Cayón, P Fernández‐Gil, M Hernández‐Guerra, M Mayorga, …

    • Year: 2001

    • Citations: 971

  • Advancing the global public health agenda for NAFLD: Consensus statement

    • Authors: JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, …

    • Year: 2022

    • Citations: 683

Daniel Akyeampong | Medicine and Dentistry | Best Researcher Award

Dr. Daniel Akyeampong | Medicine and Dentistry | Best Researcher Award

General Surgery Resident at Medical University of South Carolina, United States

Dr. Daniel K. Akyeampong, MD, born on August 13, 1993, is an emerging leader in the field of general surgery and medical education. Currently a resident in General Surgery at the Medical University of South Carolina, he has demonstrated a profound commitment to both clinical practice and academic achievement. He holds dual roles as a mentor and educator, fostering future physicians while simultaneously contributing to advancements in surgical care. A natural communicator, Daniel excels in patient-centered care and effective communication, which has earned him multiple recognitions, including the Trauma Llama Award in 2025. His dedication to the medical field is complemented by his active involvement in various professional societies such as the American College of Surgeons and the Eastern Association for the Surgery of Trauma. With a focus on both clinical excellence and research, Daniel is poised to make significant contributions to the medical community in the years to come.

Education

Daniel K. Akyeampong’s educational journey reflects a deep commitment to academic excellence and medical innovation. He earned his Bachelor of Science degree from Virginia Commonwealth University in 2015, graduating cum laude. Following his undergraduate studies, Daniel pursued his Doctor of Medicine (MD) at the University of Virginia School of Medicine, completing his degree in 2021. His rigorous academic training was followed by an internship at Vanderbilt University in General Surgery, before he embarked on his residency at the Medical University of South Carolina. Throughout his education, Daniel consistently demonstrated a passion for both learning and teaching, as evidenced by his involvement in multiple teaching and mentorship roles. His academic achievements are further underscored by prestigious awards, including the Bowman Scholar award and numerous merit scholarships, which highlight his academic dedication and promise as a future leader in the medical field.

Professional Experience

Daniel K. Akyeampong has accumulated valuable professional experience in both clinical practice and academic settings. His clinical journey began during his internship in General Surgery at Vanderbilt University, where he honed his surgical skills and deepened his understanding of patient care. In 2022, Daniel began his residency at the Medical University of South Carolina, continuing to develop his expertise in general surgery. He has actively participated in various trauma and surgical care initiatives, where his communication and patient-centered approach have earned him recognition. Additionally, Daniel’s leadership abilities extend beyond patient care, as he has taken on roles such as Administrative Chief Resident for 2025. His involvement in various committees, including the James Ramsay Surgical History Society and the Medical Society of Virginia, highlights his commitment to advancing the profession through service and leadership. Daniel’s experience as a Nationally Certified Pharmacy Technician also adds to his comprehensive understanding of healthcare systems, further enhancing his capability as a surgeon and educator.

Research Interests

Dr. Daniel Akyeampong’s research interests primarily focus on the intersection of surgery, trauma care, and medical education. He has a keen interest in exploring clinical and surgical innovations that enhance patient outcomes, particularly in trauma and emergency surgical settings. Daniel’s research has already been acknowledged with a Larry S. Nichter Research Award finalist recognition, which highlights his potential for making significant contributions to the field. He is particularly driven by the need for advancements in surgical techniques and protocols that improve patient survival rates in trauma situations. In addition to his clinical research interests, Daniel is dedicated to the advancement of medical education, focusing on improving teaching methods and mentorship in surgical training. His interest in education is evident in his multiple awards for teaching excellence and his active involvement in mentoring medical students and residents. By combining clinical expertise with research, Daniel seeks to contribute to both practical improvements in patient care and the academic growth of future surgeons.

Awards and Honors

Throughout his medical career, Dr. Daniel Akyeampong has received numerous awards and honors that reflect his dedication, excellence, and leadership within the medical community. Notable among these is the Trauma Llama Award (2025), recognizing his exceptional communication and patient-centered care during pediatric trauma activations. Additionally, Daniel has earned the Resident Award for Excellence in Student Teaching (2023, 2024), which highlights his outstanding contributions to medical education and his role in mentoring medical students. He has also been nominated for the prestigious Golden Apple Excellence in Teaching Award in 2023 and 2024, an honor given to faculty members nominated by students for excellence in teaching. As a finalist for the Larry S. Nichter Research Award in 2021, Daniel has demonstrated his commitment to impactful research in the medical field. His academic excellence is further underscored by several merit-based scholarships, such as the Bowman Scholar award and the Society of the Cincinnati Scholarship. These awards serve as a testament to his potential for continued success in both academic and clinical medicine.

Conclusion

Daniel K. Akyeampong shows strong potential for the Best Researcher Award, particularly through his combination of academic excellence, clinical expertise, and leadership. His research contributions, while recognized, could be enhanced by a more robust publication record and broader scope of research. With more focus on these areas, he has the potential to become a leading figure in surgical and clinical research.

Publications Top Notes

  • Epidemiology of Symptomatic Non-Union/Malunion Rib Fractures

    • Author: Daniel Akyeampong, Alexander Hoey, Ronald Gross, Evert Eriksson

    • Year: 2025

    • Citation: Akyeampong D, Hoey A, Gross R, Eriksson E. Epidemiology of Symptomatic Non-Union/Malunion Rib Fractures. Surgeries. 2025 Apr; 6(2):32. DOI: 10.3390/surgeries6020032

  • Anatomy of the Interchondral Joints and the Effects on Mobility of Ribs

    • Author: Daniel Akyeampong, Alexander Hoey, Aakash Patel, Andrew Privette, William Ganske, Justin Halmark, Christopher Muir, Steven Kubalak, Evert Eriksson

    • Year: 2024

    • Citation: Akyeampong D, Hoey A, Patel A, Privette AR, Ganske W, Halmark J, Muir C, Kubalak SW, Eriksson EA. Anatomy of the Interchondral Joints and the Effects on Mobility of Ribs. The Journal of Trauma and Acute Care Surgery. 2024 Sep 6; DOI: 10.1097/ta.0000000000004430

  • Racial and Gender Discrimination in Hand Surgery Letters of Recommendation

    • Author: Bradford PS, Daniel Akyeampong, MA 2nd Fleming, Andrew Dacus, AB Chhabra, DEGEORGE BRENT

    • Year: 2021

    • Citation: Bradford PS, Akyeampong D, Fleming MA 2nd, Dacus AR, Chhabra AB, DeGeorge B. Racial and Gender Discrimination in Hand Surgery Letters of Recommendation. The Journal of Hand Surgery. 2021 Aug 20; DOI: 10.1016/j.jhsa.2021.07.009

  • Three-dimensional Printing and Craniosynostosis Surgery

    • Author: Soldozy S, K. Yağmurlu, Daniel K. Akyeampong, Richard Burke, PF Morgenstern, RF Keating, JS Black, JA Jane Jr, HR Syed

    • Year: 2021

    • Citation: Soldozy S, Yağmurlu K, Akyeampong DK, Burke R, Morgenstern PF, Keating RF, Black JS, Jane JA Jr, Syed HR. Three-dimensional Printing and Craniosynostosis Surgery. Child’s Nervous System. 2021 Mar 29; DOI: 10.1007/s00381-021-05133-8

  • Systematic Review of Functional Mapping and Cortical Reorganization in the Setting of Arteriovenous Malformations, Redefining Anatomical Eloquence

    • Author: Soldozy S, Daniel K. Akyeampong, DL Barquin, Pedro Norat, Kaan Yağmurlu, JD Sokolowski, KA Sharifi, P Tvrdik, MS Park, MYS Kalani

    • Year: 2020

    • Citation: Soldozy S, Akyeampong DK, Barquin DL, Norat P, Yagmurlu K, Sokolowski JD, Sharifi KA, Tvrdik P, Park MS, Kalani MYS. Systematic Review of Functional Mapping and Cortical Reorganization in the Setting of Arteriovenous Malformations, Redefining Anatomical Eloquence. Frontiers in Surgery. 2020 Sep 30; DOI: 10.3389/fsurg.2020.514247

  • Consequences of Chronic Frequent Premature Atrial Contractions: Association with Cardiac Arrhythmias and Cardiac Structural Changes

    • Author: Sampath Gunda, Daniel Akyeampong, J. Gomez-Arroyo, Daniel G. Jovin, Gurukripa Narayan Kowlgi, Karoly Kaszala, Tan AY, JN Koneru, Jordana Kron, KA Ellenbogen et al.

    • Year: 2019

    • Citation: Gunda S, Akyeampong D, Gomez-Arroyo J, Jovin DG, Kowlgi GN, Kaszala K, Tan AY, Koneru JN, Kron J, Ellenbogen KA. Consequences of Chronic Frequent Premature Atrial Contractions: Association with Cardiac Arrhythmias and Cardiac Structural Changes. Journal of Cardiovascular Electrophysiology. 2019 Aug 1; DOI: 10.1111/jce.14067

 

Dr. Eleni Tsianaka | Neurosurgery Award | Best Researcher Award

Dr. Eleni Tsianaka | Neurosurgery Award | Best Researcher Award

Dr. Eleni Tsianaka, Kuwait Hospital, Kuwait

Dr. Eleni Tsianaka is a dedicated neurosurgeon from Greece, currently practicing in Kuwait. She earned her medical degree from Thrace University in Bulgaria in 2004 and completed her residency in Neurosurgery at the University Hospital of Larissa, Greece. Dr. Tsianaka has a board certification in Greece and medical licenses as a specialist neurosurgeon from both the Irish and Cyprus Medical Councils. In 2017, she completed a Clinical and Research Fellowship in Spine Neurosurgery at the “N.N. Burdenko” National Medical Research Center in Moscow, under the mentorship of Prof. Nikolay Konovalov. Dr. Tsianaka was the first Greek female neurosurgeon to hold an international administrative position, serving on the EANS IM Committee from 2018 to 2022, and is actively involved in various scientific initiatives, including her role as an ambassador for the European Association for Cancer Research. In 2023, she obtained her Ph.D. in Neurosurgery, focusing on intra-cranial pressure and anatomical changes during cranioplasty. She is also pursuing a Doctorate of Business Administration in Healthcare Management at the Rushford Business School in Switzerland, supported by a Presidential Scholarship. Dr. Tsianaka is passionate about leadership, teamwork, and overcoming challenges, particularly as a woman in a predominantly male field, and aims to continue advancing her professional and personal development.

Professional Profile:

Google scholar

Summary of Suitability for the Best Researcher Award: Dr. Eleni Tsianaka

Dr. Eleni Tsianaka, a distinguished neurosurgeon from Greece currently practicing in Kuwait, exemplifies the qualities of an exceptional researcher and leader in her field. Her academic journey began with a medical degree from Thrace University in Bulgaria, followed by rigorous residency training in Neurosurgery at the University Hospital of Larissa in Greece. Dr. Tsianaka’s commitment to professional development is evident in her completion of a Clinical and Research Fellowship in Spine Neurosurgery at the prestigious “N.N. Burdenko” National Medical Research Center in Moscow.

Education:

  1. Medical Degree (MD)
    • Institution: Thrace University, Bulgaria
    • Year: 2004
  2. Residency Training in Neurosurgery
    • Institution: University Hospital of Larissa, University of Thessaly, Greece
  3. Clinical and Research Fellowship in Spine Neurosurgery
    • Institution: “N.N. Burdenko” National Medical Research Center of Neurosurgery, Moscow, Russia
    • Year: Completed in 2017
  4. Ph.D. in Neurosurgery
    • Focus: Intra-cranial pressure study and its behavior during cranioplasty
    • Institution: Medical School of the University of Thessaly, Greece
    • Year: 2023
  5. Doctorate of Business Administration (DBA) in Healthcare Management
    • Institution: Rushford Business School, James Lind Institute, Geneva, Switzerland
    • Focus: Risks and crisis management in healthcare organizations
    • Status: Currently enrolled with a Presidential Scholarship

Work Experience:

  1. Neurosurgeon
    • Location: International Hospital, Salmiya, Kuwait
    • Years: Since 2018
  2. EANS IM Committee Member
    • Role: International administrative position
    • Years: 2018 – 2022
  3. Research and Scientific Activities
    • Involved in various projects leading to publications, book chapters, congress presentations, and lectures.
    • Actively engaged as an ambassador for the European Association for Cancer Research.